Overview

Treatment of Women After Postpartum Haemorrhage

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to compare the efficacy of IV high single dose infusion of iron isomaltoside 1000 to standard medical care in women with PPH evaluated as physical fatigue.

Phase:

Phase 3

Details

Lead Sponsor:

Pharmacosmos A/S

Collaborator:

BioStata

Treatments:

Ferric Compounds
Iron
Iron isomaltoside 1000